Speaker

Dr. Richard Kramer earned a Ph.D. in Neurobiology at UC Berkeley in 1985, did postdoctoral research at Brandeis University and Columbia University, and was appointed Assistant Professor at the University of Miami School of Medicine in 1993. He returned to UC Berkeley in 2000, advancing to Full Professor in 2007 and C.H. & Annie Li Professor of Molecular Mechanism of Disease in 2009. Dr. Kramer maintains diverse research interests in ion channel and synapse function, information processing in the retina, and development of treatments for vision loss. Dr. Kramer co-directed the NIH Nanomedicine Development Center and is Director of the NEI Vision Science CORE at UC Berkeley. His awards include the Eureka Award from the NIH, the Thome Foundation Award for Macular Degeneration Research, and the Wynn-Gund and Gund-Harrington Awards from Foundation Fighting Blindness. He is Founder of Photoswitch Therapeutics, Inc., which aims to develop drugs and gene therapies for reviving vision in blinding diseases.

« Go Back